Teva Agrees To End IP Suit Over Aricept Patent
Generics maker Teva Pharmaceuticals USA Inc. has agreed to suspend litigation over a compound patent for Eisai Co. Ltd.'s popular Alzheimer's drug Aricept, effectively ending Teva's bid to manufacture a generic...To view the full article, register now.
Already a subscriber? Click here to view full article